Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
LRMR | US
-0.14
-1.74%
Healthcare
Biotechnology
30/06/2024
30/08/2024
7.91
8.06
8.16
7.82
Larimar Therapeutics Inc. a clinical-stage biotechnology company focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601 which is in Phase 2 clinical trial for the treatment of Friedreich's ataxia a rare progressive and fatal genetic disease. The company is headquartered in Bala Cynwyd Pennsylvania.
View LessLow Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
High 6-Month Volatility (>65%)
Smallcap (300M - 2B USD)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
45.2%1 month
52.5%3 months
82.9%6 months
77.4%-
-
2.39
0.03
0.02
-4.13
-
-
-65.51M
504.71M
504.71M
-
-
-
-
-37.48
9.53
8.70
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.79
Range1M
1.81
Range3M
4.40
Rel. volume
0.59
Price X volume
1.34M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
PureTech Health plc | PRTC | Biotechnology | 23 | 550.43M | 1.46% | n/a | 29.73% |
GH Research PLC Ordinary Shares | GHRS | Biotechnology | 10.5 | 546.30M | -4.28% | n/a | 0.43% |
Terns Pharmaceuticals Inc. | TERN | Biotechnology | 7.62 | 536.23M | -0.78% | n/a | 0.11% |
Fulcrum Therapeutics Inc | FULC | Biotechnology | 8.55 | 533.53M | -2.17% | n/a | 3.53% |
Sage Therapeutics Inc | SAGE | Biotechnology | 8.43 | 514.65M | 4.20% | n/a | 0.22% |
Alector Inc | ALEC | Biotechnology | 5.28 | 513.86M | 1.15% | n/a | 23.98% |
Anavex Life Sciences Corp | AVXL | Biotechnology | 6.02 | 510.47M | 0.84% | n/a | 0.00% |
Valneva SE | VALN | Biotechnology | 7.32 | 509.30M | -0.27% | n/a | 126.08% |
Quanterix Corporation | QTRX | Biotechnology | 13.03 | 500.08M | -1.59% | n/a | 11.75% |
Absci Corporation Common Stock | ABSI | Biotechnology | 4.4 | 499.65M | 2.33% | n/a | 6.02% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
ACCO Brands Corporation | ACCO | Building Products & Equipment | 5.48 | 524.97M | 0.55% | n/a | 174.23% |
Lincoln Educational Services Corporation | LINC | Building Products & Equipment | 12.45 | 391.86M | -0.16% | 49.80 | 88.92% |
ONEWATER MARINE INC. | ONEW | Recreational Vehicles | 24.03 | 385.84M | 0.33% | n/a | 286.96% |
Marine Products Corporation | MPX | Recreational Vehicles | 9.4 | 326.35M | 0.00% | 12.70 | 0.00% |
CPI Card Group Inc | PMTS | Building Products & Equipment | 28.64 | 316.93M | -0.52% | 18.84 | -621.78% |
MCBC Holdings Inc | MCFT | Recreational Vehicles | 18.53 | 314.66M | -0.70% | 36.33 | 26.79% |
Virco Mfg. Corporation | VIRC | Building Products & Equipment | 15.53 | 251.70M | 1.70% | 9.96 | 15.44% |
Kewaunee Scientific Corporation | KEQU | Building Products & Equipment | 53.7 | 152.52M | -0.37% | 8.42 | 71.47% |
Saga Communications Inc | SGA | Broadcasting - Radio | 14.72 | 92.17M | -2.06% | 14.72 | 7.10% |
Urban One Inc | UONEK | Broadcasting - Radio | 1.38 | 76.89M | 5.34% | n/a | 268.43% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -4.13 | 0.97 | Cheaper |
Ent. to Revenue | - | 3,681.29 | - |
PE Ratio | - | 39.83 | - |
Price to Book | 2.39 | 14.54 | Cheaper |
Dividend Yield | - | 2.19 | - |
Std. Deviation (3M) | 82.86 | 76.13 | Par |
Debt to Equity | 0.03 | -2.05 | Expensive |
Debt to Assets | 0.02 | 0.25 | Cheaper |
Market Cap | 504.71M | 4.04B | Emerging |